"10.1371_journal.pone.0068992","plos one","2013-07-18T00:00:00Z","Yoshihiro Matsumoto; Tomokazu Matsuura; Haruyo Aoyagi; Mami Matsuda; Su Su Hmwe; Tomoko Date; Noriyuki Watanabe; Koichi Watashi; Ryosuke Suzuki; Shizuko Ichinose; Kenjiro Wake; Tetsuro Suzuki; Tatsuo Miyamura; Takaji Wakita; Hideki Aizaki","Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan; Department of Laboratory Medicine, the Jikei University School of Medicine, Tokyo, Japan; Research Center for Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Liver Research Unit, Minophagen Pharmaceutical Co., Ltd., Tokyo, Japan; Department of Infectious Diseases, Hamamatsu University School of Medicine, Hamamatsu, Japan","Conceived and designed the experiments: YM NW RS SI TS T. Miyamura T. Matsuura TW SH K. Wake K. Watashi. Performed the experiments: YM H. Aoyagi H. Aizaki. Analyzed the data: YM H. Aoyagi H. Aizaki. Contributed reagents/materials/analysis tools: MM TD. Wrote the manuscript: YM H. Aoyagi.","K. Wake is employed by Minophagen Pharmaceutical Co., Ltd. GL (20<beta>-carboxyl-11-oxo-30-norolean-12-en-<beta>-yl-2-O-<beta>-D-glucopyranuronosyl-<beta>-D-glucopyranosiduronic acid) was kindly provided by the Minophagen Pharmaceutical Co., Ltd.  There are no further patents, products in development or marketed products to declare.  This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","07","Yoshihiro Matsumoto","YM",15,TRUE,6,2,2,2,TRUE,TRUE,TRUE,2,"8;11",TRUE
